Neurotherapy is a term that was dubbed by EEG diagnostician and quantum physicist Juri Kropotov in 2009. Neurotherapy refers to the combined use of traditional neurofeedback (which is based on a system of biofeedback) and neurostimulation (which is not).
When we at Tucson Neurofeedback refer to neurostimulation, we are referring to the tailored, appropriate use of transcranial alternating and direction current stimulation (tACS and tDCS, respectively), random noise stimulation, electromagnetic field therapy (pEMF), photobiomodulation, and repetitive transcranial magnetic stimulation.
While neurofeedback is a treatment approach that has been around since the 1970s and is backed by a substantiative body of research, neurostimulation modalities are newer technologies that are showing promising research results. In his seminal work, DeRidder (2014) found that neurostimulation changes functional connectivity of the brain as well as the brain’s emergent properties.
This translates to the effective use of neurostimulation in dissolving old, dysfunctional brainwave patterns to make way for new patterns of behavior that reflect greater connectivity and optimal functioning. These shifts in brainwaves may correlate with emergent properties such as reduction of symptoms and improved quality of life. Such an integration of neurostimulation with neurofeedback is new to the field (incorporated in 2016); a small minority of practitioners are using these modalities in tandem.